JPH07264992A - Peptide-containing composition and production thereof - Google Patents
Peptide-containing composition and production thereofInfo
- Publication number
- JPH07264992A JPH07264992A JP6085336A JP8533694A JPH07264992A JP H07264992 A JPH07264992 A JP H07264992A JP 6085336 A JP6085336 A JP 6085336A JP 8533694 A JP8533694 A JP 8533694A JP H07264992 A JPH07264992 A JP H07264992A
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- acid
- containing composition
- component
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 84
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 64
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 108091005804 Peptidases Proteins 0.000 claims abstract description 30
- 102000035195 Peptidases Human genes 0.000 claims abstract description 27
- 150000001413 amino acids Chemical class 0.000 claims abstract description 21
- 239000005018 casein Substances 0.000 claims abstract description 21
- 235000019833 protease Nutrition 0.000 claims abstract description 15
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 14
- 235000019658 bitter taste Nutrition 0.000 claims abstract description 13
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000021240 caseins Nutrition 0.000 claims abstract description 13
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000004365 Protease Substances 0.000 claims abstract description 12
- 235000019419 proteases Nutrition 0.000 claims abstract description 12
- -1 aromatic amino acids Chemical class 0.000 claims abstract description 11
- 239000003957 anion exchange resin Substances 0.000 claims abstract description 9
- 239000012528 membrane Substances 0.000 claims abstract description 9
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims abstract description 8
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims abstract description 8
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000011347 resin Substances 0.000 claims abstract description 8
- 229920005989 resin Polymers 0.000 claims abstract description 8
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 7
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims abstract description 7
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000012466 permeate Substances 0.000 claims abstract description 5
- 230000002378 acidificating effect Effects 0.000 claims abstract description 4
- 230000007935 neutral effect Effects 0.000 claims abstract description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract 3
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 claims description 18
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 claims description 12
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 claims description 12
- LCZUOKDVTBMCMX-UHFFFAOYSA-N 2,5-Dimethylpyrazine Chemical compound CC1=CN=C(C)C=N1 LCZUOKDVTBMCMX-UHFFFAOYSA-N 0.000 claims description 10
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 10
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 10
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 10
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 10
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- OXCKCFJIKRGXMM-UHFFFAOYSA-N 2-ethyl-5-methylpyrazine Chemical compound CCC1=CN=C(C)C=N1 OXCKCFJIKRGXMM-UHFFFAOYSA-N 0.000 claims description 8
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 8
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 8
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 claims description 6
- 229930003836 cresol Natural products 0.000 claims description 6
- 230000000774 hypoallergenic effect Effects 0.000 claims description 6
- 239000001934 2,5-dimethylpyrazine Substances 0.000 claims description 5
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims description 5
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 5
- 239000005639 Lauric acid Substances 0.000 claims description 5
- 235000021314 Palmitic acid Nutrition 0.000 claims description 5
- 235000021319 Palmitoleic acid Nutrition 0.000 claims description 5
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 claims description 5
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 5
- 229960002446 octanoic acid Drugs 0.000 claims description 5
- 239000001908 2-ethyl-5-methylpyrazine Substances 0.000 claims description 4
- CLUWOWRTHNNBBU-UHFFFAOYSA-N 3-methylthiopropanal Chemical compound CSCCC=O CLUWOWRTHNNBBU-UHFFFAOYSA-N 0.000 claims description 4
- FWGYRFWKBWPRJD-UHFFFAOYSA-N 4-methyl-2,3-dihydrofuran Chemical compound CC1=COCC1 FWGYRFWKBWPRJD-UHFFFAOYSA-N 0.000 claims description 4
- 102000014171 Milk Proteins Human genes 0.000 claims description 4
- 108010011756 Milk Proteins Proteins 0.000 claims description 4
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims description 4
- 235000021239 milk protein Nutrition 0.000 claims description 4
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 4
- 230000000007 visual effect Effects 0.000 claims description 3
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 239000006103 coloring component Substances 0.000 claims 1
- 230000000593 degrading effect Effects 0.000 claims 1
- 235000013336 milk Nutrition 0.000 abstract description 7
- 239000008267 milk Substances 0.000 abstract description 7
- 210000004080 milk Anatomy 0.000 abstract description 7
- 239000000047 product Substances 0.000 abstract description 5
- 230000000172 allergic effect Effects 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 238000001179 sorption measurement Methods 0.000 abstract description 3
- 238000000354 decomposition reaction Methods 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 description 26
- 229940024606 amino acid Drugs 0.000 description 26
- 235000013305 food Nutrition 0.000 description 21
- 235000019645 odor Nutrition 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 208000026935 allergic disease Diseases 0.000 description 5
- 235000013350 formula milk Nutrition 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- 235000020940 control diet Nutrition 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- IAEGWXHKWJGQAZ-UHFFFAOYSA-N trimethylpyrazine Chemical compound CC1=CN=C(C)C(C)=N1 IAEGWXHKWJGQAZ-UHFFFAOYSA-N 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- 201000010538 Lactose Intolerance Diseases 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
- 239000004473 Threonine Substances 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 235000021588 free fatty acids Nutrition 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 235000020256 human milk Nutrition 0.000 description 3
- 210000004251 human milk Anatomy 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
- 229960000310 isoleucine Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000008939 whole milk Nutrition 0.000 description 3
- VQKFNUFAXTZWDK-UHFFFAOYSA-N 2-Methylfuran Chemical compound CC1=CC=CO1 VQKFNUFAXTZWDK-UHFFFAOYSA-N 0.000 description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 102100034866 Kallikrein-6 Human genes 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000013566 allergen Substances 0.000 description 2
- 229920001429 chelating resin Polymers 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 125000000962 organic group Chemical group 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- PCLIRWBVOVZTOK-UHFFFAOYSA-M 2-(1-methylpyrrolidin-1-ium-1-yl)ethyl 2-hydroxy-2,2-diphenylacetate;iodide Chemical compound [I-].C=1C=CC=CC=1C(O)(C=1C=CC=CC=1)C(=O)OCC[N+]1(C)CCCC1 PCLIRWBVOVZTOK-UHFFFAOYSA-M 0.000 description 1
- WRFPVMFCRNYQNR-UHFFFAOYSA-N 2-hydroxyphenylalanine Chemical compound OC(=O)C(N)CC1=CC=CC=C1O WRFPVMFCRNYQNR-UHFFFAOYSA-N 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- COISXLOKVDVSKV-UHFFFAOYSA-N C(C)C1=NC=C(N=C1)C.CC1=NC=C(N=C1)C Chemical compound C(C)C1=NC=C(N=C1)C.CC1=NC=C(N=C1)C COISXLOKVDVSKV-UHFFFAOYSA-N 0.000 description 1
- JDXZFZVCDKHPIB-UHFFFAOYSA-N CC1=NC=C(N=C1C)C.C(C)C1=NC=C(N=C1)C Chemical compound CC1=NC=C(N=C1C)C.C(C)C1=NC=C(N=C1)C JDXZFZVCDKHPIB-UHFFFAOYSA-N 0.000 description 1
- NJMWATZHUNEYGH-UHFFFAOYSA-N CC=1CCOC1.C1(=CC=CC=C1)CC=O Chemical compound CC=1CCOC1.C1(=CC=CC=C1)CC=O NJMWATZHUNEYGH-UHFFFAOYSA-N 0.000 description 1
- YZXFVCLWAPVSDV-UHFFFAOYSA-N CSCCC=O.CC=1N=C(C(=NC1)C)C Chemical compound CSCCC=O.CC=1N=C(C(=NC1)C)C YZXFVCLWAPVSDV-UHFFFAOYSA-N 0.000 description 1
- 229920006051 Capron® Polymers 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000027472 Galactosemias Diseases 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- LFUMWSPWAZBMCN-UHFFFAOYSA-N benzaldehyde 3-methylsulfanylpropanal Chemical compound C(C1=CC=CC=C1)=O.CSCCC=O LFUMWSPWAZBMCN-UHFFFAOYSA-N 0.000 description 1
- GLCFXEJCEKCVTE-UHFFFAOYSA-N benzaldehyde;2-phenylacetaldehyde Chemical compound O=CC1=CC=CC=C1.O=CCC1=CC=CC=C1 GLCFXEJCEKCVTE-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 235000021542 oral nutrition Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- HOKBIQDJCNTWST-UHFFFAOYSA-N phosphanylidenezinc;zinc Chemical compound [Zn].[Zn]=P.[Zn]=P HOKBIQDJCNTWST-UHFFFAOYSA-N 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、低アレルギー性であっ
て、苦味及び臭気成分(以下表記した場合を除き不快臭
という。)の低減されたペプチド含有組成物に関する。
また、本発明は、このペプチド含有組成物の製造方法
及びこのペプチドを含有させた食品あるいは栄養組成物
等に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a peptide-containing composition which is hypoallergenic and has reduced bitterness and odor components (hereinafter referred to as unpleasant odor unless otherwise indicated).
The present invention also relates to a method for producing the peptide-containing composition, a food or nutritional composition containing the peptide, and the like.
【0002】[0002]
【従来技術】食物アレルギ−症の患者が若年層を中心に
増加の傾向にあると言われている昨今では、栄養摂取を
特に重要とする年代層であるこれらの若年層の人達に向
けた低アレルギ−食品が様々な形で開発されている。一
般的には、牛乳、卵、大豆等に代表される動植物蛋白質
を基質として酵素で加水分解し、そのアレルゲン性を低
減させた素材を窒素源とした食品を提供している例が見
られる。一方、病中病後の患者や健康指向派の人々、或
いはスポ−ツ選手等にとっては、食品を経口摂取した後
の体内での消化・吸収性も重要であり、この点でも蛋白
質の酵素加水分解物を窒素源とした食品が注目されてき
ている。2. Description of the Related Art Nowadays, it is said that the number of patients with food allergic diseases tends to increase mainly in the younger age group. Nowadays, the hypoallergenicity of these younger people who are especially important in nutritional intake is low. -Food products are developed in various forms. In general, there are examples in which animal and vegetable proteins typified by milk, eggs, soybeans, etc. are hydrolyzed with an enzyme as a substrate, and a material having a reduced allergenicity is provided as a nitrogen source. On the other hand, digestion and absorption in the body after ingestion of food is also important for post-illness patients, health-oriented people, and sports players. Foods that use food as a nitrogen source have been attracting attention.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、その加
水分解物は一般的に風味、色沢等において食品としては
あまり好まれない物が多く、甘味料、香料等の配合によ
って最終食品の風味を配慮しているものの、効果が顕著
に現れることは稀であり、上記対象者にとっては、経口
摂取に多少なりとも苦痛あるいは支障をきたすものであ
った。さらに、酵素加水分解物中のチロシン、フェニル
アラニンおよびトリプトファン等の芳香族アミノ酸のレ
ベルが高いほど苦味が増し風味の点で劣るため、これら
のアミノ酸をより低減させた方がベタ−である。また母
乳中の含量に比較しても高いため、母乳近似化を目指す
母乳代替食品(乳児を対象とした低アレルギ−食品等)
にとっても牛乳蛋白質分解物中の芳香族アミノ酸のレベ
ルは支障をきたすものであった。However, many of the hydrolyzates are generally not favored as foods in terms of flavor, color and the like, and the flavor of the final food is taken into consideration by mixing sweeteners and flavors. However, the effects are rarely noticeable, and the above subjects suffered some pain or trouble in oral intake. Further, the higher the level of aromatic amino acids such as tyrosine, phenylalanine and tryptophan in the enzymatic hydrolyzate, the more bitterness is increased and the flavor is inferior. Therefore, it is better to further reduce these amino acids. In addition, since it is higher than the content in breast milk, it is a substitute for breast milk that aims to approximate breast milk (low allergic food for infants, etc.).
The level of aromatic amino acids in the milk protein hydrolyzate was also a problem for the dog.
【0004】上記の事情を鑑み、本発明の課題は、苦
味、不快臭が低減され、かつ色調のきれいな低アレルギ
ー性ペプチド含有組成物及びその製法を提供することに
ある。さらに具体的には、本発明は乳蛋白質、特にカゼ
インを酵素で加水分解し、限外濾過処理したペプチド含
有組成物を吸着樹脂で処理することによって苦味成分で
ある芳香族アミノ酸の一部、不快臭、さらには色沢にお
ける褐色度を低減して得られる、食品素材としてより適
した低アレルギー性ペプチド含有組成物及びその製造方
法を提供することを課題とするものである。In view of the above-mentioned circumstances, an object of the present invention is to provide a hypoallergenic peptide-containing composition having reduced bitterness and unpleasant odor and a clean color and a method for producing the same. More specifically, the present invention is a method of hydrolyzing milk protein, particularly casein with an enzyme, and treating a peptide-containing composition subjected to ultrafiltration with an adsorption resin to partially dissipate a part of an aromatic amino acid, which is a bitter component, It is an object of the present invention to provide a hypoallergenic peptide-containing composition that is more suitable as a food material and that can be obtained by reducing the odor and further the brownness in the color stripe, and a method for producing the same.
【0005】[0005]
【課題を解決するための手段】本発明者らは、上記目的
を達成すべく、種々検討を重ねた結果、本発明を完成し
たものである。すなわち、本発明は、最大分子量3000以
下のペブチド20〜50重量%と遊離アミノ酸50〜80重量%
からなり、かつアミノ酸組成中チロシン、フェニルアラ
ニンおよびトリプトファン等の芳香族アミノ酸の量が0.
3 〜7.2 重量%含有する、低アレルギー性であって、苦
味及び不快臭の低減されたペプチド含有組成物である。The present inventors have completed the present invention as a result of various studies to achieve the above object. That is, the present invention relates to a peptide having a maximum molecular weight of 3000 or less of 20 to 50% by weight and free amino acid of 50 to 80% by weight
And the amount of aromatic amino acids such as tyrosine, phenylalanine and tryptophan in the amino acid composition is 0.
A peptide-containing composition containing 3 to 7.2% by weight, which is hypoallergenic and has reduced bitterness and unpleasant odor.
【0006】また、本発明のペプチドは臭気成分の含有
量が 35ppm以下に低減されているものである。このよう
な臭気成分は、酪酸、カプロン酸、カプリン酸、カプリ
ル酸、ラウリン酸、パルミチン酸、パルミトレイン酸、
ジメチル・ジスルフィド、2,5−ジメチルピラジン、
2−エチル−5−メチルピラジン、トリメチル・ピラジ
ン、3−メチルチオ−プロパナール、ベンズアルデヒ
ド、ベンゼンアセトアルデヒド、2,3−ジヒドロ−4
−メチルフラン、フルフラール、フルフリルアルコール
及びクレゾールからなる群から選択される少なくとも一
種の成分である。Further, the peptide of the present invention has an odor component content reduced to 35 ppm or less. Such odorous components include butyric acid, caproic acid, capric acid, caprylic acid, lauric acid, palmitic acid, palmitoleic acid,
Dimethyl disulfide, 2,5-dimethylpyrazine,
2-ethyl-5-methylpyrazine, trimethylpyrazine, 3-methylthio-propanal, benzaldehyde, benzeneacetaldehyde, 2,3-dihydro-4
-At least one component selected from the group consisting of methylfuran, furfural, furfuryl alcohol and cresol.
【0007】さらに、本発明のペプチド含有組成物は、
粉末状においてその色調がC光(標準の光)および2度
視野(等色関数)の条件下で、表色系 (Hunter-Lab) を
用いて色差を測定した時の明度(L値)が80〜95、褐色
度(a値)が-4.0〜0.5 及び黄色度(b値)が13〜16.3
である前記組成のペプチド含有組成物に関する。Further, the peptide-containing composition of the present invention comprises
The lightness (L value) when measuring the color difference using a color system (Hunter-Lab) under the condition that the color tone of the powder is C light (standard light) and 2 degree visual field (color matching function) 80 to 95, brownness (a value) -4.0 to 0.5 and yellowness (b value) 13 to 16.3
And a peptide-containing composition of the above composition.
【0008】また、本発明はカゼインを酸性化でプロテ
アーゼで処理し、次いで中性下でペプチダーゼ処理し、
限外濾過膜で処理し、さらに陰イオン交換樹脂で処理す
ることよりなる前記組成の低アレルギー性で、苦味及び
不快臭の低減されたペプチド含有組成物の製造法に関す
る。The present invention also provides that casein is treated with a protease by acidification and then with a peptidase under neutral conditions,
The present invention relates to a method for producing a peptide-containing composition having a low allergenicity, reduced bitterness and unpleasant odor, which is obtained by treating with an ultrafiltration membrane and then with an anion exchange resin.
【0009】本発明のペプチド含有組成物は、乳児用調
製粉乳、フォローアップミルク、経腸・経口栄養剤、一
般健康食品、アレルギー疾患用食品あるいは乳糖不耐
症、ガラクトース血症患者用無乳糖食品等に窒素源とし
て配合するものである。The peptide-containing composition of the present invention comprises infant formula, follow-up milk, enteral / oral nutritional supplements, general health foods, foods for allergic diseases or lactose intolerance, lactose-free foods for patients with galactoseemia. Etc. as a nitrogen source.
【0010】次に本発明のペプチド含有組成物の製造方
法について具体的に説明する。本発明のペプチド含有組
成物の製造方法はカゼインを原料としてプロテア−ゼで
加水分解するA工程と、この処理物をペプチダ−ゼで加
水分解するB工程と、限外濾過膜処理よって透過させる
C工程と、陰イオン交換樹脂で処理することによって苦
味成分であるチロシン、フェニールアラニン及びトリプ
トファンの芳香族アミノ酸、不快臭及び色沢における褐
色度を低減させるD工程を含むものである。A工程にお
けるプロテア−ゼとしては、アスペルギルス糸状菌由来
の酸性プロテアーゼ、中性プロテアーゼおよびペプチダ
ーゼを含む蛋白質分解酵素が最適である。具体的にはモ
ルシンF(盛進製薬社製)、プロテアーゼM(天野製薬
社製)、スミチームAP及びスミチームRP(新日本化
学工業社製)等が例示でき、これらの酵素の1 または2
種以上を選択して使用する。またB工程におけるペプチ
ダーゼとしては、リゾプス属由来のプロテアーゼ及びペ
プチダーゼを含む複合酵素、特にペプチダ−ゼ活性の高
い蛋白質分解酵素が好ましい。具体的には、Blend
o No.2060.20、Blendo No.4500.10(Impe
rial Biotechnology Limited製)、カルボキシルペプチ
ダーゼ(ぺんてる社製)、IP酵素、モルシンF(盛進
製薬社製)、ペプチダーゼR(天野製薬社製)等が例示
でき、これらの酵素の1 または2 種以上を選択して使用
することができる。Next, the method for producing the peptide-containing composition of the present invention will be specifically described. The method for producing the peptide-containing composition of the present invention comprises a step A in which casein is used as a raw material for hydrolysis with protease, a step B in which this treated product is hydrolyzed with peptidase, and a step C for permeating by ultrafiltration membrane treatment. It comprises a step and a step D in which treatment with an anion exchange resin reduces the aromatic amino acids of tyrosine, phenylalanine and tryptophan, which are bitter components, unpleasant odors and brownness in color. As a protease in the step A, a proteolytic enzyme containing an acidic protease, a neutral protease and a peptidase derived from Aspergillus filamentous fungi is most suitable. Specific examples thereof include Morcin F (manufactured by Seishin Pharmaceutical Co., Ltd.), Protease M (manufactured by Amano Pharmaceutical Co., Ltd.), Sumiteam AP and Sumiteam RP (manufactured by Shin Nippon Chemical Industry Co., Ltd.), and one or two of these enzymes can be mentioned.
Select and use at least one species. As the peptidase in the step B, a complex enzyme containing a protease derived from the genus Rhizopus and a peptidase, particularly a proteolytic enzyme having a high peptidase activity is preferable. Specifically, Blend
o No.2060.20, Blendo No.4500.10 (Impe
rial Biotechnology Limited), carboxyl peptidase (Pentel), IP enzyme, Morcine F (Morijin Pharmaceutical), Peptidase R (Amano Pharmaceutical), etc., and one or more of these enzymes can be used. It can be selected and used.
【0011】カゼインにこれらの酵素を作用させる好ま
しい条件として、A工程ではカゼインの固形率を5 〜20
重量%程度にし、pH3 〜4 で温度35〜55℃、好ましく
は40〜50℃で10〜60時間、好ましくは14〜20時間にて、
プロテアーゼの添加率20〜200 単位/g-カゼインの下で
加水分解する。次にB工程ではA工程で分解した溶液を
pH6 〜8 に調整して温度35〜55℃、好ましくは40〜50
℃で1〜10時間、好ましくは5 〜8 時間にてペプチダー
ゼの添加率1000〜6000単位/g-カゼインの下で加水分解
する。尚、pH調整剤としてはA工程では18〜35%塩酸
を、B工程では水酸化カリウム、水酸化ナトリウムある
いは水酸化カルシウムを用いる。A工程における酵素反
応の終点はペプチド濃度を測定して 400〜500 μMとな
った時点で判定し、またB工程における酵素反応の終点
はペプチド濃度が 600〜700 μMとなった時点で判定す
る。また酵素作用を失活させるには95〜120 ℃で4秒〜
30分間加熱して行う。C工程では、素材をセラミックと
し、分画分子量が 10000Da以下である限外濾過膜によ
り、運転温度10〜70℃、運転圧力1〜10bar にて行い、
未分解物等の不要物を除去し、その透過液を得る。好ま
しくは運転温度40〜60℃、運転圧力2〜6 bar にて行う
ことが望ましい。このようにすると最大分子量3000以下
のペプチドとアミノ酸とを上記比率で含有する透過液を
得る。D工程は陰イオン交換樹脂、例えばアニオン性吸
着樹脂により、処理温度 2〜90℃、SV値1 〜6 、BV
値1 〜30にて行う。好ましくは処理温度 2〜60℃、SV
値2 〜5 、BV値10〜25にて行うことが望ましい。陰イ
オン交換樹脂としては、例えばデュオライトA-561(住友
化学社製) 、アンバーライトIRA-94s(オルガノ社
製)、アンバーライトIRA-68 (オルガノ社製) 、ダイア
イオン WA 10(三菱化成社製)、ダイアイオンWA 30
(三菱化成社製) 等が用いられる。この陰イオン交換樹
脂処理により、ペプチト含有組成物中の苦味成分である
芳香族アミノ酸および不快臭が吸着除去され、また、そ
の色沢も褐色度が低減され透明となる。これを粉末状に
した場合は、より乳白色になる。As a preferred condition for causing these enzymes to act on casein, in the step A, the solid content of casein is 5 to 20.
In about 3% by weight, pH 3 to 4 at a temperature of 35 to 55 ° C, preferably 40 to 50 ° C for 10 to 60 hours, preferably 14 to 20 hours,
Hydrolyze under the addition rate of 20-200 units / g-casein of protease. Next, in step B, the solution decomposed in step A is adjusted to pH 6 to 8 and the temperature is adjusted to 35 to 55 ° C, preferably 40 to 50 ° C.
The hydrolysis is carried out at 1 ° C. for 1 to 10 hours, preferably 5 to 8 hours under the addition ratio of peptidase of 1000 to 6000 units / g-casein. As the pH adjuster, 18 to 35% hydrochloric acid is used in the step A, and potassium hydroxide, sodium hydroxide or calcium hydroxide is used in the step B. The end point of the enzyme reaction in the step A is judged at the time when the peptide concentration is measured to reach 400 to 500 μM, and the end point of the enzyme reaction in the step B is judged at the time when the peptide concentration reaches 600 to 700 μM. In order to inactivate the enzyme action, it takes 4 seconds at 95-120 ℃.
Heat for 30 minutes. In the process C, the material is ceramic, and the ultrafiltration membrane having a cut-off molecular weight of 10,000 Da or less is used at an operating temperature of 10 to 70 ° C. and an operating pressure of 1 to 10 bar.
Unnecessary substances such as undecomposed substances are removed to obtain the permeated liquid. It is preferable to carry out at an operating temperature of 40 to 60 ° C and an operating pressure of 2 to 6 bar. In this way, a permeate containing a peptide having a maximum molecular weight of 3000 or less and an amino acid in the above ratio is obtained. In the step D, an anion exchange resin such as an anionic adsorption resin is used, and the treatment temperature is 2 to 90 ° C., the SV value is 1 to 6, and the BV is
Use a value of 1 to 30. Treatment temperature is preferably 2 to 60 ° C, SV
It is desirable that the value is 2 to 5 and the BV value is 10 to 25. Examples of anion exchange resins include Duolite A-561 (Sumitomo Chemical Co., Ltd.), Amberlite IRA-94s (Organo), Amberlite IRA-68 (Organo), Diaion WA 10 (Mitsubishi Kasei) Made), Diaion WA 30
(Manufactured by Mitsubishi Kasei) or the like is used. By this anion exchange resin treatment, the aromatic amino acid and the unpleasant odor which are bitter components in the peptite-containing composition are adsorbed and removed, and the brownness of the colorant is reduced to make it transparent. When it is made into powder, it becomes more milky white.
【0012】このようにして得られたペプチド含有組成
物は、次に示すような組成である。一 般 組 成 (固形分中の重量%) 全構成アミノ酸量 80 〜 90 (全構成アミノ酸中) ペプチド量(最大分子量3000以下) 20 〜 50 遊離アミノ酸量 50 〜 80 糖 分 0 〜 1 その他 (灰分及び脂肪) 9 〜 20ア ミ ノ 酸 組 成(重量%) アスパラギン酸 5.7 〜 8.9 スレオニン 3.6 〜 5.4 セリン 4.9 〜 7.3 グルタミン酸 18.9 〜 22.7 プロリン 9.8 〜 11.8 グリシン 1.3 〜 2.0 アラニン 2.7 〜 4.5 シスチン 0.2 〜 0.6 バリン 5.9 〜 7.2 メチオニン 0.7 〜 4.3 イソロイシン 2.7 〜 6.4 ロイシン 5.2 〜 13.7 チロシン 0.2 〜 2.8 フェニルアラニン 0.1 〜 4.0 リジン 6.3 〜 13.4 ヒスチジン 2.5 〜 3.8 トリプトファン 0.0 〜 0.4 アルギニン 3.0 〜 5.7臭気成分 (ppm) (遊離脂肪酸) 酪酸 1.7 〜 6.8 カプロン酸 3.4 〜13.4 カプリル酸 1.5 〜6.1 カプリン酸 1.8 〜7.3 ラウリン酸 0.01 以下 パルミチン酸 0.01 以下パルミトレイン酸 0.01 〜 0.12 ジメチル ジスルフィド 0.01 以下 (Dimethyl disulfide) 2,5-ジメチルピラジン 0.01 以下 (2,5-Dimethylpyrazine) 2-エチル-5- メチルピラジン 0.01 以下 (2-Ethyl-5-methylpyrazine) トリメチル・ピラジン 0.01 以下 (Trimethyl pyrazine) 3-メチルチオ−プロパナール 0.01〜 0.15 (3-(Methylthio)-propanal) ベンズアルデヒド 0.01 以下 (Benzaldehyde) ベンゼンアセトアルデヒド 0.06〜 0.45 (Benzeneacetoaldehyde) 2, 3- ジヒドロ-4- メチルフラン 0.01 以下 (2, 3-Dihydro-4-methyl Furan) フルフラール 0.1 以下 (Furfural) フルフリル アルコール 0.1 以下 (Furfuryl alcohol) クレゾール 0.01 以下 (Cresol) 色 調 度 ( 参考値:全粉乳) L値(明 度) 80〜95 89.79 a値(褐色度) -4.0〜0.5 - 3.56 b値(黄色度) 13〜16.3 14.18 尚色調度は、粉末状においてC光(標準の光)および2
度視野(等色関数)の条件下で、表色系(Hunter
−Lab)を用いて色差を測定した時の値である。The peptide-containing composition thus obtained has the following composition. General composition (% by weight in solid content) Total constituent amino acids 80 to 90 (in all constituent amino acids) Peptide amount (maximum molecular weight 3000 or less) 20 to 50 Free amino acids 50 to 80 Sugar 0 to 1 Other (ash And fat) 9-20 Amino acid Composition (% by weight) Aspartic acid 5.7-8.9 Threonine 3.6-5.4 Serine 4.9-7.3 Glutamic acid 18.9-22.7 Proline 9.8-11.8 Glycine 1.3-2.0 Alanine 2.7-4.5 Cysteine 0.2-0.6 Valine 5.9 to 7.2 Methionine 0.7 to 4.3 Isoleucine 2.7 to 6.4 Leucine 5.2 to 13.7 Tyrosine 0.2 to 2.8 Phenylalanine 0.1 to 4.0 Lysine 6.3 to 13.4 Histidine 2.5 to 3.8 Tryptophan 0.0 to 0.4 Arginine 3.0 to 5.7 Odor component (ppm) (free fatty acid) Butyric acid 1.7 ~ 6.8 Caproic acid 3.4 ~ 13.4 Caprylic acid 1.5 ~ 6.1 Capric acid 1.8 ~ 7.3 Lauric acid 0.01 or less Palmitic acid 0.01 or less Palmitoleic acid 0.01 to 0.12 Dimethyl disulfide 0.01 (Dimethyl disulfide) 2,5- dimethyl pyrazine 0.01 (2,5-Dimethylpyrazine) 2- ethyl-5-methylpyrazine 0.01 (2-Ethyl-5-methylpyrazine ) trimethyl pyrazine 0.01 or less (Trimethyl pyrazine) 3-methylthio-propanal 0.01 to 0.15 (3- (Methylthio) -propanal) Benzaldehyde 0.01 or less (Benzaldehyde) Benzeneacetaldehyde 0.06 to 0.45 (Benzeneacetoaldehyde) 2,3-dihydro-4-methylfuran 0.01 or less (2, 3-Dihydro-4-methyl Furan) Furfural 0.1 or less (Furfural) Furfuryl alcohol 0.1 or less (Furfuryl alcohol) Cresol 0.01 or less (Cresol) Color tone (reference value: whole milk powder) L value (brightness) 80- 95 89.79 a value (brownness) -4.0 to 0.5-3.56 b value (yellowness) 13 to 16.3 14.18 The color tone is C light (standard light) and 2 in powder form.
Under the condition of the visual field (color matching function), the color system (Hunter)
-Lab) is the value when the color difference is measured.
【0013】このペプチド含有組成物は、ペプチドの最
大分子量を3000以下に低分子化することによって免疫系
に認識されにくくなり、これを20〜50重量%含有させる
ことによってアレルゲンが低下し、また芳香族アミノ酸
や臭気成分量を規制することにより苦味、不快臭の発生
を防止することができる。さらには不快臭や色沢におけ
る褐色度を低減されたものである。また得られたペプチ
ド組成物は、液状であるが、濃縮乾燥して粉末にしても
よいし、あるいは液状のまま各種食品や栄養組成物の窒
素源として配合する。得られた食品や栄養組成物は、低
アレルギー性であって、かつ不快臭や苦味、さらには色
沢における褐色度を低減されたものである。尚、本発明
でいう食品や栄養組成物には乳児用調製乳、乳児用調製
粉乳、フオローアップミルク、アレルギ−疾患用食品、
経腸・経口栄養剤、一般健康食品或いは乳糖不耐症、ガ
ラクト−ス血症患者向けの無乳糖食品等がある。This peptide-containing composition makes it difficult for the immune system to recognize it by lowering the maximum molecular weight of the peptide to 3000 or less, and by containing 20 to 50% by weight of the peptide, the allergen is lowered and the aroma is reduced. It is possible to prevent bitterness and unpleasant odor by controlling the amounts of group amino acids and odorous components. Furthermore, the unpleasant odor and the brownness in the color are reduced. The obtained peptide composition is in a liquid form, but may be concentrated and dried into a powder, or may be blended in a liquid form as a nitrogen source for various foods and nutritional compositions. The obtained food or nutritional composition is hypoallergenic and has reduced unpleasant odors and bitterness and brownness in the color zawa. The foods and nutritional compositions referred to in the present invention include infant formula, infant formula, follow-up milk, allergic disease foods,
There are enteral / oral nutritional supplements, general health foods, lactose intolerance, and lactose-free foods for patients with galactosemia.
【0014】以下に本発明のペプチド含有組成物のアレ
ルギー阻止効果を確認するための試験例を示す。The test examples for confirming the allergic inhibitory effect of the peptide-containing composition of the present invention are shown below.
(ペプチド含有組成物の調製)固形率が7 %でpHを3.
9 に調整したカゼイン溶液に、80単位/g−カゼインの
プロテアーゼ(天野製薬社製 プロテアーゼM)を添加
し、45.5℃で16.5時間反応処理をした。更に、この溶液
のpHを6.1 に調整した後、4800単位/g−カゼインの
ペプチダーゼ(天野製薬社製 ペプチダーゼR)を添加
し、45.5℃で16.5時間反応処理をした。この加水分解処
理液を50℃で、5000Daの膜を有する限外ろ過装置によ
り3 barで処理して透過液を得た。そして更に陰イオ
ン交換樹脂(住友化学社製 デュオライトA-561)が充填
されたカラムに通液速度SV=3.5 で通液し、ペプチド
含有組成物を得た。(Preparation of peptide-containing composition) Solid content is 7% and pH is 3.
80 units / g-casein of protease (Protease M manufactured by Amano Pharmaceutical Co., Ltd.) was added to the casein solution adjusted to 9, and the mixture was reacted at 45.5 ° C. for 16.5 hours. Furthermore, after adjusting the pH of this solution to 6.1, 4800 units / g-casein peptidase (Peptidase R manufactured by Amano Pharmaceutical Co., Ltd.) was added, and the reaction was carried out at 45.5 ° C. for 16.5 hours. The hydrolyzed solution was treated at 50 ° C. with an ultrafiltration device having a membrane of 5000 Da at 3 bar to obtain a permeate. Then, the mixture was further passed through a column packed with an anion exchange resin (Duolite A-561 manufactured by Sumitomo Chemical Co., Ltd.) at a flow rate of SV = 3.5 to obtain a peptide-containing composition.
【0015】(飼料の調製)試験用飼料の組成は、ミ
ルクカゼイン20重量%含有食( 以下、「対照食」と略
す) 、上記調製のペプチド含有組成物10重量%含有食
(以下、「ペプチド含有食」と略す)を調製し、そして
これらに脂肪源として精製大豆油、糖質源としてαコー
ンスターチ、食物繊維源としてセルロース、AIN−76
組成によるミネラル混合物、ビタミン混合物を混合し、
飼料を調製した。(Preparation of feed) The composition of the test feed was 20% by weight of milk casein (hereinafter referred to as "control diet"), 10% by weight of the peptide-containing composition prepared above (hereinafter referred to as "peptide"). Abbreviated as "containing food"), and refined soybean oil as a fat source, α-corn starch as a sugar source, cellulose as a dietary fiber source, and AIN-76.
Mix mineral mixture, vitamin mixture by composition,
The feed was prepared.
【0016】(アレルゲン阻止効果試験)乳児期のWist
ar系雄ラット(14日令、10匹、チャールスリバー社より
購入)を対照群5 匹とペプチド含有組成物投与群5 匹に
分けた。そして対照食群およびペプチド含有食投与群に
それぞれ上記で調製した飼料を与え、2週間後に血液を
採取した。抗ラットIgE 抗体(ノルディック社製)を使
って血液中のIgE を測定した。その結果を次に示す。こ
こにみられるように、ペプチド含有組成物食群は、対照
食群に比較して明らかにアレルギー低減作用があること
が分った。(Allergen blocking effect test) Wist in infancy
Male ar rats (14 days old, 10 rats, purchased from Charles River) were divided into a control group of 5 rats and a peptide-containing composition administration group of 5 rats. Then, the control diet group and the peptide-containing diet administration group were each fed with the above-prepared feed, and blood was collected 2 weeks later. IgE in blood was measured using an anti-rat IgE antibody (Nordic). The results are shown below. As seen here, the peptide-containing composition food group, it was Tsu amount that is apparently allergic lowering action compared to the control diet group.
【0017】 *対照食群との間に有意差あり(p<0.05)[0017] * Significantly different from the control diet group (p <0.05)
【0018】以下に本発明の実施例を示す。Examples of the present invention will be shown below.
実施例1 市販の粉末カゼインを用いて前記A〜C工程を次の条件
で実施してペプチド含有組成物Iを得た後、さらにD工
程を実施してペプチド含有組成物IIを得た。 (A工程) 基 質 濃 度 7% プロテアーゼ添加率 80単位/g−カゼイン 反 応 温 度 45.5℃ 反 応 時 間 16.5時間 反 応 p H 3.9 (B工程) 基 質 濃 度 7% ペプチダーゼ添加率 4800単位/g−カゼイン 反 応 温 度 44.5℃ 反 応 時 間 7時間 反 応 p H 6.1 (C工程) 限外濾過膜の分画分子量 10,000 限外濾過処理温度 50℃ 限外濾過処理圧力 3bar (D工程) 使用樹脂 デュオライトA561 (住友化学社製) 樹脂処理温度 30℃ 樹脂SV値 3.5 樹脂BV値 13 以上の処理によって芳香族アミノ酸の一部除去で苦味が
低減され、フレ−バ−及び色沢が改良されたペプチド含
有組成物IIを得ることができた。該ペプチド含有組成物
の組成を以下に記載する。Example 1 The steps A to C were carried out under the following conditions using a commercially available powdered casein to obtain a peptide-containing composition I, and then a step D was further carried out to obtain a peptide-containing composition II. (Process A) Base concentration 7% Protease addition rate 80 units / g-Casein Reaction temperature 45.5 ° C Reaction time 16.5 hours Reaction pH 3.9 (Process B) Base concentration 7% Peptidase addition rate 4800 units / g-casein reaction temperature 44.5 ° C reaction time 7 hours reaction pH 6.1 (step C) molecular weight cutoff of ultrafiltration membrane 10,000 ultrafiltration temperature 50 ℃ Ultrafiltration treatment pressure 3 bar (Process D) Resin used Duolite A561 (Sumitomo Chemical Co., Ltd.) Resin treatment temperature 30 ℃ Resin SV value 3.5 Resin BV value 13 A part of aromatic amino acid can be removed by treatment A peptide-containing composition II having reduced bitterness and improved flavor and color tone could be obtained. The composition of the peptide-containing composition is described below.
【0019】 一般組成(固形分中の重量%) ヘ゜フ゜チト゛組成物I ヘ゜フ゜チト゛組成物II 最大分子量 1,700 1,700 全アミノ酸量 85.0 84.5 ペプチド量 25.5 22.5 遊離アミノ酸量 59.5 62.0 糖分 0.0 0.0 その他(灰分・脂肪) 15.0 15.5 アミノ酸組成(重量%) ヘ゜フ゜チト゛組成物I ヘ゜フ゜チト゛組成物II アスパラギン酸 6.9 7.1 スレオニン 4.1 4.3 セリン 5.6 5.9 グルタミン酸 20.3 21.4 プロリン 10.7 10.9 グリシン 1.8 1.7 アラニン 2.9 3.2 シスチン 0.4 0.4 バリン 6.4 6.7 メチオニン 2.8 2.8 イソロイシン 5.2 4.9 ロイシン 9.4 9.8 チロシン 4.0 1.7 フェニルアラニン 5.0 3.0 リジン 7.7 8.9 ヒスチジン 3.0 3.2 トリプトファン 1.2 0.2 アルギニン 3.5 4.0 臭気成分(ppm) ヘ゜フ゜チト゛組成物I ヘ゜フ゜チト゛組成物II (遊離脂肪酸) 酪酸 34.0 4.1 カプロン酸 67.0 9.9 カプリル酸 30.6 4.6 カプリン酸 36.4 3.5 ラウリン酸 0.100 0.01以下 パルミチン酸 0.122 0.01以下 パルミトレイン酸 0.211 0.077 ジメチル ジスルフィド 0.058 0.01以下 2,5-ジメチルピラジン 0.109 0.01以下 2-エチル-5- メチルピラジン 0.022 0.01以下 トリメチル・ピラジン 0.034 0.01以下 3-メチルチオ−プロパナール 0.232 0.104 ベンズアルデヒド 0.127 0.01以下 ベンゼンアセトアルデヒド 1.252 0.303 2, 3- ジヒドロ-4- メチルフラン 0.012 0.01以下 フルフラール 0.10 0.1 以下 フルフリルアルコール 0.11 0.1 以下 クレゾール 0.044 0.01 以下 色 調 度 ヘ゜フ゜チト゛組成物I ヘ゜フ゜チト゛組成物II 全粉乳 L値(明 度) 78.45 87.92 89.79 a値(褐色度) 0.89 - 2.19 -3.56 b値(黄色度) 16.50 15.81 14.18 General composition (% by weight in solid content) Peptide composition I Peptide composition II Maximum molecular weight 1,700 1,700 Total amino acid amount 85.0 84.5 Peptide amount 25.5 22.5 Free amino acid amount 59 .5 62.0 Sugar 0.0 0.0 Others (ash / fat) 15.0 15.5 Amino acid composition (% by weight) Peptide composition I Heptide composition II Aspartic acid 6.9 7.1 Threonine 4.1 4.3 Serine 5.6 5.9 Glutamic acid 20.3 21.4 Proline 10.7 10.9 Glycine 1.8 1.7 Alanine 2.9 3.2 Cystine 0.4 0.4 Valine 6.4 6 .7 Methionine 2.8 2.8 Isoleucine 5.2 4.9 Leucine 9.4 9.8 Tyrosine 4.0 1.7 Phenylalanine 5.0 3.0 Lysine 7.7 8.9 Histidine 3.0 3.2 Tryptophan 1.2 0.2 Arginine 3.5 4.0 Odor component (ppm) Hepeptidyl composition I Hepeptidyl composition II (free fatty acid) Butyric acid 34.0 4.1 Caproic acid 67.0 9.9 Caprylic acid 30.6 4.6 Capric acid 36.4 3.5 Lauric acid 0.100 0.01 or less Palmitic acid 0.122 0.01 or less Palmitoleic acid 0.211 0.077 Dimethyl disulfide 0.058 0.01 or less 2,5-Dimethylpyrazine 0.109 0.01 or less 2-Ethyl-5-methylpyrazine 0.022 0.01 or less Trimethyl・ Pyrazine 0.034 0.01 or less 3-Methylthio-propanal 0.232 0.104 Benzaldehyde 0.127 0.01 or less Benzene acetaldehyde 1.252 0.303 2,3-Dihydro-4-methylfuran 0.012 0.01 or less Furfural 0.10 0.1 or less Furfuryl alcohol 0.11 0.1 or less Cresol 0.044 0.01 or less Color tone Degree Composition I Peptide Composition II Whole milk powder L value (brightness) 78.45 87.92 89.79 a value (brownness) 0.89-2.19 -3.56 b value (yellowness) 16.50 15.81 14.18
【0020】実施例2 市販の粉末カゼインを用いて前記A〜C工程を次の条件
で実施してペプチド含有組成物Iを得た後、D工程を実
施してペプチド含有組成物IIを得た。 (A工程) 基 質 濃 度 10% プロテアーゼ添加率 95単位/g−カゼイン 反 応 温 度 50.0℃ 反 応 時 間 15.0時間 反 応 p H 4.1 (B工程) 基 質 濃 度 10% ペプチダーゼ添加率 3500単位/g−カゼイン 反 応 温 度 49.5℃ 反 応 時 間 5時間 反 応 p H 7.0 (C工程) 限外濾過膜分画分子量 10,000 限外濾過処理温度 60℃ 限外濾過処理圧力 4.5bar (D工程) 樹脂 ダイアイオン WA10 (三菱化成社製) 樹脂処理温度 50℃ 樹脂SV値 2.5 樹脂BV値 10 以上の処理によって芳香族アミノ酸の一部が除去され苦
味が低減され、フレ−バ−及び色沢が改良されたペプチ
ド含有組成物IIを得ることができた。該ペプチド含有組
成物の組成を以下に記載する。Example 2 The steps A to C were carried out under the following conditions using a commercially available powdered casein to obtain a peptide-containing composition I, and then a step D was carried out to obtain a peptide-containing composition II. . (Process A) Base concentration 10% Protease addition rate 95 units / g-casein Reaction temperature 50.0 ° C Reaction time 15.0 hours Reaction pH 4.1 (Process B) Base concentration 10% Peptidase addition rate 3500 units / g-casein reaction temperature 49.5 ° C reaction time 5 hours reaction pH 7.0 (C process) ultrafiltration membrane molecular weight 10,000 ultrafiltration treatment temperature 60 ℃ Ultrafiltration pressure 4.5 bar (D process) Resin Diaion WA10 (manufactured by Mitsubishi Kasei) Resin treatment temperature 50 ° C Resin SV value 2.5 Resin BV value 10 A part of aromatic amino acid is removed by treatment As a result, a peptide-containing composition II having reduced bitterness and improved flavor and color was obtained. The composition of the peptide-containing composition is described below.
【0021】 一般組成(固形分中の重量%) ヘ゜フ゜チト゛組成物I ヘ゜フ゜チト゛組成物II 最大分子量 2,000 2,000 全アミノ酸量 82.0 82.5 ペプチド量 25.0 22.0 遊離アミノ酸量 56.5 60.5 糖 分 0.0 0.0 その他(灰分・脂肪) 18.0 17.5 アミノ酸組成(重量%) ヘ゜フ゜チト゛組成物I ヘ゜フ゜チト゛組成物II アスパラギン酸 6.8 7.5 スレオニン 4.1 4.5 セリン 5.8 6.2 グルタミン酸 20.1 21.2 プロリン 10.6 11.1 グリシン 1.9 1.5 アラニン 3.0 3.4 シスチン 0.4 0.4 バリン 6.3 6.8 メチオニン 2.8 2.5 イソロイシン 5.2 4.8 ロイシン 9.4 10.2 チロシン 3.4 1.3 フェニルアラニン 5.1 1.5 リジン 7.6 9.4 ヒスチジン 2.9 3.4 トリプトファン 1.2 0.0 アルギニン 3.5 4.3 臭気成分(ppm) ヘ゜フ゜チト゛組成物I ヘ゜フ゜チト゛組成物II (遊離脂肪酸) 酪酸 38.5 4.5 カプロン酸 70.0 10.1 カプリル酸 33.2 4.5 カプリン酸 39.8 3.9 ラウリン酸 0.092 0.01以下 パルミチン酸 0.109 0.01以下 パルミトレイン酸 0.204 0.098 ジメチル ジスルフィド 0.080 0.01 以下 2,5-ジメチルピラジン 0.098 0.01 以下 2-エチル-5- メチルピラジン 0.035 0.01 以下 トリメチル・ピラジン 0.029 0.01 以下 3-メチルチオ−プロパナール 0.198 0.116 ベンズアルデヒド 0.146 0.01 以下 ベンゼンアセトアルデヒド 1.189 0.496 2,3-ジヒドロ-4- メチルフラン 0.01以下 0.01 以下 フルフラール 0.105 0.1 以下 フルフリルアルコール 0.1 以下 0.1 以下 クレゾール 0.037 0.01 以下 色 調 度 ヘ゜フ゜チト゛組成物I ヘ゜フ゜チト゛組成物II 全粉乳 L値(明 度) 77.59 85.69 89.79 a値(褐色度) 0.93 -2.01 -3.56 b値(黄色度) 16.62 15.53 14.18 General composition (% by weight in solid content) Peptide composition I Peptide composition II Maximum molecular weight 2,000 2,000 Total amino acid amount 82.0 82.5 Peptide amount 25.0 22.0 Free amino acid amount 56 .5 60.5 Sugar 0.0 0.0 Others (ash / fat) 18.0 17.5 Amino acid composition (% by weight) Peptide composition I Hepeptide composition II Aspartic acid 6.8 7.5 Threonine 4. 1 4.5 serine 5.8 6.2 glutamic acid 20.1 21.2 proline 10.6 11.1 glycine 1.9 1.5 alanine 3.0 3.4 cystine 0.4 0.4 valine 6.3 6.8 Methionine 2.8 2.5 Isoleucine 5.2 4.8 Leucine 9.4 10.2 Tyrosine 3.4 1.3 Phenylalanine 5.1 1. 5 Lysine 7.6 9.4 Histidine 2.9 3.4 Tryptophan 1.2 0.0 Arginine 3.5 4.3 Odorant (ppm) Hepeptidic composition I Hepeptidic composition II (free fatty acid) Butyric acid 38.5 4.5 Capron Acid 70.0 10.1 Caprylic acid 33.2 4.5 Capric acid 39.8 3.9 Lauric acid 0.092 0.01 or less Palmitic acid 0.109 0.01 or less Palmitoleic acid 0.204 0.098 Dimethyl disulfide 0.080 0.01 or less 2,5-Dimethylpyrazine 0.098 0.01 or less 2-Ethyl-5-methylpyrazine 0.035 0.01 or less Trimethylpyrazine 0.029 0.01 or less 3-Methylthio-propanal 0.198 0.116 Benzaldehyde 0.146 0.01 or less Benzeneacetaldehyde 1.189 0.496 2,3-Dihydro-4-methylfuran 0.01 or less 0.01 or less Furfural 0.105 0.1 or less Furfuryl alcohol 0.1 or less 0.1 or less Cresol 0.037 0.01 The following color tone of Bae ° Tito Bu composition I Pepuchito Bu composition II whole milk powder L value (Lightness) 77.59 85.69 89.79 a value (tan degree) 0.93 -2.01 -3.56 b value (yellowness) 16.62 15.53 14.18
【0022】実施例3 実施例1記載のペプチド含有組成物IIの固形分17kg、デ
キストリン50kg、澱粉3kg 、蔗糖10kg及びビタミン、ミ
ネラル類2.5kg を60℃の温湯500kg で溶解・混合した。
これと乳化剤0.1kg を予め添加混合した50℃の植物性調
整脂肪17.5kgとを混合し均質化して、120℃で4 秒間殺菌
処理した後、常法により濃縮、乾燥してアレルギ−疾患
用及び無乳糖食品100kg を得た。Example 3 17 kg of the solid content of the peptide-containing composition II described in Example 1, 50 kg of dextrin, 3 kg of starch, 10 kg of sucrose and 2.5 kg of vitamins and minerals were dissolved and mixed in 500 kg of hot water at 60 ° C.
This was mixed with 0.1 kg of an emulsifier in advance and mixed with 17.5 kg of a vegetable-modified fat at 50 ° C., homogenized, sterilized at 120 ° C. for 4 seconds, concentrated and dried by a conventional method, and used for allergic diseases. 100 kg of lactose-free food was obtained.
【0023】実施例4 実施例1記載のペプチド組成物II(液状)100kg を50℃
に加温して、該液に乳清蛋白質濃縮物(WPC)5kg 、
デキストリン10kg、蔗糖2kg 及びビタミンとミネラル類
0.5kg を混合・溶解した。これに乳化剤0.02kgを予め添
加混合した45℃の植物性調整脂肪 6.5kgとを混合し均質
化後、 140℃で 2秒間滅菌処理して経腸・経口栄養剤 1
24kgを得た。該滅菌液を無菌的に缶充填後、容器ごと急
冷して最終製品を得た。Example 4 100 kg of the peptide composition II (liquid form) described in Example 1 was heated to 50 ° C.
After heating to 5 kg of whey protein concentrate (WPC),
Dextrin 10kg, sucrose 2kg and vitamins and minerals
0.5 kg was mixed and dissolved. To this, add 0.02 kg of emulsifier beforehand and mix with 6.5 kg of vegetable modified fat at 45 ° C to homogenize and sterilize at 140 ° C for 2 seconds to enteral / oral nutrition 1
I got 24 kg. The sterilized solution was aseptically filled in a can and then rapidly cooled together with the container to obtain a final product.
【0024】[0024]
【発明の効果】本発明のペプチド含有組成物は、カゼイ
ンを酵素で二段階で加水分解し、この分解物を限外ろ過
膜およびアニオン交換樹脂で処理したものであるため、
全構成アミノ酸が最大分子量 3000 以下のペプチドと遊
離アミノ酸からなり、かつ芳香族アミノ酸が低減されい
るものである。しかも、加水分解によって生じる不快臭
も低減され、色彩も粉末の場合は乳本来の乳白色に近似
し、液体の場合は無色透明となる。このため、アレルゲ
ン性が低減されていることはもちろん、ペプチド含有組
成物に避けることができなかった苦味や不快臭も低減さ
れたものである。上記の理由から本発明のペプチド含有
組成物は、例えば乳児用調製乳、乳児用調製粉乳、フオ
ローアップミルク、アレルギー疾患用食品、経腸・経口
栄養剤、一般健康食品或いは乳糖不耐症、ガラクトース
血症患者向けの無乳糖食品等に容易に用いることができ
るものである。The peptide-containing composition of the present invention is obtained by hydrolyzing casein in two steps with an enzyme, and treating the decomposed product with an ultrafiltration membrane and an anion exchange resin.
All constituent amino acids consist of peptides with a maximum molecular weight of 3000 or less and free amino acids, and aromatic amino acids are reduced. In addition, the unpleasant odor caused by hydrolysis is reduced, and the color is similar to the milky white inherent in milk when it is a powder, and colorless and transparent when it is a liquid. Therefore, not only the allergenicity is reduced, but also the bitterness and unpleasant odor, which cannot be avoided by the peptide-containing composition, are reduced. From the above reasons, the peptide-containing composition of the present invention is, for example, infant formula, infant formula, follow-up milk, food for allergic diseases, enteral / oral nutritional supplement, general health food or lactose intolerance, galactose. It can be easily used for lactose-free foods and the like for patients with blood sugar.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C12P 21/06 9282−4B // C07K 2/00 8318−4H (72)発明者 重松 明典 埼玉県川越市新宿町5−11−3 むさしの 寮 (72)発明者 宿野部 幸孝 埼玉県川越市南古谷上6083−8 B−2− 205─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical indication C12P 21/06 9282-4B // C07K 2/00 8318-4H (72) Inventor Akinori Shigematsu Saitama Prefecture 5-11-3 Shinjuku-cho, Kawagoe City Musashino Dormitory (72) Inventor Yukitaka Shunobe 6083-8 Minami Furuueue, Kawagoe City, Saitama Prefecture B-2-205
Claims (5)
によって得ることができ、最大分子量3000以下のペブチ
ド20〜50重量%と遊離アミノ酸50〜80重量%と
からなり、かつ遊離アミノ酸組成中のチロシン、フェニ
ルアラニンおよびトリプトファンの芳香族アミノ酸が
0.3〜7.2重量%含有されていることを特徴とする
低アレルギー性であって、苦味及び臭気成分の低減され
たペプチド含有組成物。1. A milk protein, which can be obtained by degrading milk protein with a proteolytic enzyme, comprises 20 to 50% by weight of pebutide having a maximum molecular weight of 3000 or less and 50 to 80% by weight of free amino acid. A hypoallergenic, peptide-containing composition having reduced bitterness and odor components, characterized by containing 0.3 to 7.2% by weight of aromatic amino acids of tyrosine, phenylalanine and tryptophan.
減されている請求項1記載のペプチド含有組成物。2. The peptide-containing composition according to claim 1, wherein the content of the odorous component is reduced to 35 ppm or less.
ル酸、カプリン酸、ラウリン酸、パルミチン酸、パルミ
トレイン酸、ジメチル・ジスルフィド、2,5−ジメチ
ルピラジン、2−エチル−5−メチルピラジン、トリメ
チル・ピラジン、3−メチルチオ−プロパナール、ベン
ズアルデヒド、ベンゼンアセトアルデヒド、2,3−ジ
ヒドロ−4−メチルフラン、フルフラール、フルフリル
アルコール、及びクレゾールからなる群から選択される
少なくとも1種の成分である請求項1又は2記載のペプ
チド含有組成物。3. The odorous component is butyric acid, caproic acid, caprylic acid, capric acid, lauric acid, palmitic acid, palmitoleic acid, dimethyl disulfide, 2,5-dimethylpyrazine, 2-ethyl-5-methylpyrazine, trimethyl. -At least one component selected from the group consisting of pyrazine, 3-methylthio-propanal, benzaldehyde, benzeneacetaldehyde, 2,3-dihydro-4-methylfuran, furfural, furfuryl alcohol, and cresol. The peptide-containing composition according to 1 or 2.
2度視野(等色関数)の条件下で、表色系(Hunte
r−Lab)を用いて色差を測定した時の明度(L値)
が80〜95、褐色度(a値)が−4.0〜0.5およ
び黄色度(b値)が13〜16.3である請求項1〜3
のいずれかに記載のペプチド含有組成物。4. A color system (Hunte) under the conditions of C light (standard light) and 2 degree visual field (color matching function) in powder form.
Brightness (L value) when color difference is measured using r-Lab)
Is 80 to 95, the brownness (a value) is -4.0 to 0.5, and the yellowness (b value) is 13 to 16.3.
The peptide-containing composition according to any one of 1.
て分解し、次いで中性下でペプチダーゼ処理して分解
し、限外ろ過膜処理して最大分子量3000以下のペプチド
とアミノ酸を含有する透過液を得、更にこの透過液を陰
イオン交換樹脂で処理して苦味成分、臭気成分及び着色
成分を樹脂に吸着させて除去し、通過液を採取すること
からなる請求項1記載のペプチト含有組成物の製造方
法。5. Casein is decomposed by treatment with protease under acidic condition, then decomposed by treatment with peptidase under neutral condition, and treated with ultrafiltration membrane to obtain a permeate containing peptides and amino acids having a maximum molecular weight of 3000 or less. The peptite-containing composition according to claim 1, which further comprises treating the permeated liquid with an anion exchange resin to remove the bitterness component, odor component and coloring component by adsorbing to the resin, and collecting the passing liquid. Production method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP08533694A JP3233779B2 (en) | 1994-03-31 | 1994-03-31 | Peptide-containing composition and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP08533694A JP3233779B2 (en) | 1994-03-31 | 1994-03-31 | Peptide-containing composition and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07264992A true JPH07264992A (en) | 1995-10-17 |
JP3233779B2 JP3233779B2 (en) | 2001-11-26 |
Family
ID=13855806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP08533694A Expired - Fee Related JP3233779B2 (en) | 1994-03-31 | 1994-03-31 | Peptide-containing composition and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3233779B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2865900A1 (en) * | 2004-02-06 | 2005-08-12 | United Pharmaceuticals Sa | Hypoallergenic powdered milk formula for babies and very young children has low dose of artificial sweetener(s) to cover bitter taste |
JP2011045295A (en) * | 2009-08-27 | 2011-03-10 | Yamasa Shoyu Co Ltd | Liquid seasoning preventing production of thermally deteriorated odor and processed food |
JP2020068668A (en) * | 2018-10-29 | 2020-05-07 | 森永乳業株式会社 | Milk protein hydrolyzate and method of producing the same |
-
1994
- 1994-03-31 JP JP08533694A patent/JP3233779B2/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2865900A1 (en) * | 2004-02-06 | 2005-08-12 | United Pharmaceuticals Sa | Hypoallergenic powdered milk formula for babies and very young children has low dose of artificial sweetener(s) to cover bitter taste |
JP2011045295A (en) * | 2009-08-27 | 2011-03-10 | Yamasa Shoyu Co Ltd | Liquid seasoning preventing production of thermally deteriorated odor and processed food |
JP2020068668A (en) * | 2018-10-29 | 2020-05-07 | 森永乳業株式会社 | Milk protein hydrolyzate and method of producing the same |
Also Published As
Publication number | Publication date |
---|---|
JP3233779B2 (en) | 2001-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU600225B2 (en) | A method for treating a casein-based raw material containing phosphocaseinates of monovalent cations or derivatives thereof, resulting products and applications thereof | |
KR940003938B1 (en) | Peptide preparation a process for producing it and use of the peptide preparation | |
AU2011221852B2 (en) | Agent for preventing muscular atrophy | |
AU2009332369B2 (en) | Muscle-building agent | |
WO1996011584A1 (en) | Peptide mixture and products thereof | |
WO2010092778A1 (en) | Acid-soluble soybean protein material, and process for producing same | |
JP4619730B2 (en) | Amino acid / peptide mixture with excellent flavor and method for producing the same | |
JP3233779B2 (en) | Peptide-containing composition and method for producing the same | |
WO2022168413A1 (en) | Method for producing deprestatin-containing composition | |
WO2018079762A1 (en) | Method for producing whey protein hydrolysate having superior flavor | |
JP3408739B2 (en) | Calcium absorption promoter and calcium supplement | |
JP5695326B2 (en) | Protein synthesis promoter | |
JP3437738B2 (en) | Method for producing protein hydrolyzate with reduced odor | |
US6355297B1 (en) | Protein component for dietetic food | |
JPH0678685A (en) | Production of protein hydrolyzate without unpleasant taste | |
JP2007151427A (en) | Albumen hydrolyzate richly containing cysteine, and food and drink containing the same | |
JP4084916B2 (en) | Antihypertensive food containing raw material derived from wheat | |
RU2366263C2 (en) | Broth with preventive properties, containing protein hydrolisate and protein hydrolisate production method | |
JPH0581219B2 (en) | ||
JPH03272694A (en) | Oligopeptide mixture, production thereof and nutrition feeding composition for patient of heptic disease | |
WO2011046101A1 (en) | Fat accumulation suppressor | |
JPH0362382B2 (en) | ||
JP2019041696A (en) | Oral composition | |
US5334408A (en) | Nutrient composition containing non-phosphorylated peptides from casin-based material | |
KR20220048535A (en) | A method of preparing a hydrolysate of whey protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070921 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080921 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090921 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100921 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100921 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110921 Year of fee payment: 10 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110921 Year of fee payment: 10 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110921 Year of fee payment: 10 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120921 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130921 Year of fee payment: 12 |
|
LAPS | Cancellation because of no payment of annual fees |